-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Jining City has actively implemented the centralized procurement policy of medicines, and the 57 drugs selected have been purchased and used in various public medical institutions at all levels, effectively reducing the burden on the medical expenses of the masses.In December 2019, the state launched the first batch of centralized procurement of drugs, the 25 drugs selected for the treatment of chronic diseases such as fat reduction, blood pressure, antiviral, anti-tumor. At present, all 25 kinds of drugs are purchased and used in various public medical institutions at all levels in Jining City according to the selected price, and the selected price has decreased by an average of 59% compared with the lowest purchase price of the same drug in the expanded area in 2018.In April this year, Jining City on time to implement the country's second batch of drug centralized procurement policy, from sugar-reducing heat-reducing and other commonly used drugs to expensive anti-cancer drugs, 32 selected drugs covering a number of therapeutic areas, some of the decline of 95.9%.It is understood that the third batch of centralized procurement of 55 kinds of drugs, covering high blood pressure, diabetes, cancer disease, mental illness, anti-infection and other therapeutic areas, the results of the election will be fully implemented in Jining City on November 16. At the same time, Jining City actively promote the implementation of cross-city joint procurement with Linyi, Zhanzhuang and Luze and other places, the establishment of the "Lunan Economic Circle public medical institutions drug (supplies) procurement alliance", to further reduce the public medical institutions drug supplies transaction costs and procurement prices, reduce the burden of medical treatment of the masses. (
mass network
)